Show results for
Refine by
Microbiome Suppliers Serving Croatia
74 companies found
based inFreiburg, GERMANY
CYTENA, the premier provider of single-cell dispensers, liquid handlers and live cell analyzers, started out in 2014 as a spin-off from the Laboratory for MEMS Applications and the Hahn-Schickard Institute in Freiburg, Germany. In 2019, CYTENA ...
based inParis, FRANCE
Enterome is pioneering the discovery and development of novel pharmaceuticals based on its unrivalled understanding of the interaction between the gut microbiome and the immune system – the Microbiome-Immunoinflammation Axis. Enterome is using this ...
New generation of oral bioactives to treat inflammatory and autoimmune diseases. EndoMimicsTM are first-in-class orally available bioactives drugs based on proteins secreted by the gut bacteria that act like human hormones or cytokines. Enterome ...
based inCambridge, UNITED KINGDOM
The microbiome's most powerful innovation platform. Unlocking radical innovation by enabling the conversation between microbiome data and the scientist. The microbiome's most powerful innovation platform. Unlocking radical innovation by enabling the ...
Unifying constellations of complex, multi-dimensional data and the exploration of signals and networks of relationship undetectable by humans ...
based inWageningen, NETHERLANDS
Noldus Information Technology was established in 1989 by Lucas Noldus, founder and CEO of the company. With a Ph.D. in animal behavior from Wageningen University, he developed the company’s first software tool during his research in entomology. ...
The Observer XT is the ideal tool for many researchers because it saves you time scoring behaviors and it allows you to synchronize and analyze multiple signals (video, audio, physiology, etc) all ...
based inKenmore, AUSTRALIA
Stance Global Pty Ltd provides the unique combination of skills and resources from Stance Environmental and Stance Agriculture. Stance Environmental provides skills and technologies for processing of waste and byproducts into products suitable for ...
based inMorgan Hill, CALIFORNIA (USA)
Anaerobe Systems produces the world’s only true pre-reduced anaerobically sterilized (PRAS) culture media: poured and packaged under anaerobic conditions. Founded over 40 years ago, for scientists by scientists, Anaerobe Systems has discovered ...
based inMannheim, GERMANY
Our business is about contributing to good nutrition, with the ultimate goal of keeping people and animals healthy. We are fully aware of the responsibility this encompasses and use all our expertise to ensure that our products and services enable ...
based inSchlieren, SWITZERLAND
Based on our research, we believe that the common denominator underlying each intestinal microbiome is a network of interconnected, interdependent and metabolic functions that are essential for the host and the microbiome. PharmaBiome has developed ...
We take a bottom-up approach and engineer bacterial consortia based on their interactions. Our deep understanding of function drives the selection of individual strains, which are then co-cultured using our proprietary ...
based inCambridge, MASSACHUSETTS (USA)
Seres Therapeutics is a late-clinical stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human ...
SER-301 is an investigational, oral, rationally-designed, fermented microbiome therapeutic for the treatment of mild-to-moderate ulcerative colitis (UC). SER-301 is a consortium of multiple bacterial strains that is manufactured ...
based inHoersholm, DENMARK
In 2024, Chr. Hansen and Novozymes joined forces to form Novonesis. At Novonesis, we are leading the era of biosolutions. By leveraging the power of microbiology with science, we transform the way the world produces, consumes and lives. Novonesis ...
based inAmesbury, MASSACHUSETTS (USA)
Gloveboxes Group brings together the expertise of Inert, Erea, and Jacomex, providing a comprehensive range of containment solutions essential for controlled atmospheres and operator safety. The group offers custom and standard gloveboxes, gas ...
Gloveboxes Group specializes in custom-designed isolators and solutions to meet the evolving demands of the pharmaceutical industry, particularly for sterile and toxic applications. Their expertise spans diverse pharmaceutical sectors, ensuring safe ...
based inOrange City, IOWA (USA)
the name is Dutch in origin. In English Van Beek can be translated to From the Brook. A brook, or a stream, is a body of water which flows naturally through a landscape. As it flows, it spreads nutrients and oxygen through the land. The waterway ...
based inSomerville, MASSACHUSETTS (USA)
Finch Therapeutics is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs. With the capabilities to develop both complete and targeted ...
Our lead product candidate, CP101, is an orally administered, Complete Consortia product candidate initially targeting the prevention of recurrent CDI. The Centers for Disease Control and Prevention considers CDI to be one of the top three most ...
based inSeongnam-si, SOUTH KOREA
LISCure Biosciences Provides Novel Therapeutics to Patients with Refractory Diseases Using the LMT Platform. LISCure is developing the world’s first injectable immuno-oncology program using non-pathogenic microorganisms. We focus on the development ...
LMT (LISCure Microbiology-based Technology) Platform Consists of the Therapeutic Screening Platform, Microbial Optimization Platform, and Microbiome Database ...
based inCambridge, MASSACHUSETTS (USA)
The human body is an ecosystem. Trillions of microbes call us home. They form the human microbiome, which performs critical functions that preserve our health including modulating our immune system and providing colonization resistance against ...
From Ruslan Medzhitov's discovery of toll-like receptors (TLRs) as the key immune system receptors that detect infection, which spawned the field of innate immunity, to Dan Littman's efforts to identify and clone CD4 and CD8, molecules on the ...
based inGijón, SPAIN
Our mission is to develop novel technologies and next generation live biotherapeutic products providing innovative solutions to health care by harnessing the treasure of the human microbiota. We are developing a novel class biotherapeutic products ...
Microviable Therapeutics is developing novel technologies and next generation biotherapeutic products by harnessing the treasure of the human microbiota generating innovative solutions that enable to address unmet challenges in human ...
based inCambridge, MASSACHUSETTS (USA)
AOBiome has identified significant therapeutic opportunities caused by the adverse impact of the modern environment on human physiology. The human body relies on a system of multiple microorganisms, chemistries, and pathways which have shaped the ...
The human microbiome consists of hundreds of trillions of microorganisms, outnumbering human cells by 10 to 1 with as many as 3 million bacterial genes to our approximately 20 thousand. While the microbiome has ...
based inIrvine, CALIFORNIA (USA)
Since 1994, Zymo Research has been led by a vision to have a positive impact in the biomedical field and to contribute to the greater good of humanity. Our innovative sample collection reagents, kits and devices have been used all over the World; ...
based inKraków, POLAND
Instytut Biotechnologii Surowic i Szczepionek BIOMED Spółka Akcyjna is a Polish biotechnological company combining modernity with tradition. We manufacture biological medications (biologicals), in particular specific and non-specific bacterial ...
based inBrisbane City, AUSTRALIA
Microba’s precise microbiome analysis is built on the expertise of our innovative team at the leading edge of microbiome science. Our approach to microbiome analysis is enabling new discoveries and advancing the understanding of the microbiome in ...
Developing novel therapeutics from the human microbiome; The uncultured portion of the human gut microbiome, which is the majority of microbial species, represents untapped therapeutic opportunity. Microba has ...